Docetaxel belongs to the taxane family of anti-cancer drugs, which are commonly used in non-small cell lung cancers. They stabilize microtubules by preventing depolymerization, resulting in cell death. Pneumonitis is an uncommon side effect of docetaxel. We report a case of docetaxel induced hypersensitivity pneumonitis mimicking lymphangitic carcinomatosis in a patient with metastatic adenocarcinoma of the lung
Interstitial lung disease (ILD) is a collective term for a group of disorders that result in inflamm...
A 64-year-old woman was diagnosed with non-small cell lung cancer. Her disease was stage 4 (T2N2M1) ...
OBJECIlVE: To reportthree cases of paclitaxel-induced acutebilateral pneumonitis, as wellas to ascer...
Background: Pulmonary toxicity is a well-known complication observed with several anticancer drugs. ...
Development of pulmonary infiltrates with respiratory symptoms in patients with advanced cancer pres...
Interstitial lung disease associated with docetaxel in a patient treated for breast cancer — a case ...
Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibi...
Incidence of diffuse alveolar damage is rarely seen after administration of docetaxel used alone or ...
Abstract Taxane‐induced pneumotoxicity is rare. However, 1–5% of patients taking docetaxel may devel...
  Docetaxel belongs to taxane family of antineoplastic agents that are indicated for the treatment...
Pneumonitis is a rare but serious complication of docetaxel treatment. We report a 63-year-old woman...
Paclitaxel is frequently used for the treatment of patients with nonsmall cell lung cancer. Hypersen...
Gemcitabine and docetaxel combination chemotherapy is the standard of care for patients with unresec...
AbstractTaxanes are drugs used to treat many types of cancer, including breast and lung cancer. The ...
Docetaxel has proven effective in many solid tumors, including breast cancer. Hypersensitivity react...
Interstitial lung disease (ILD) is a collective term for a group of disorders that result in inflamm...
A 64-year-old woman was diagnosed with non-small cell lung cancer. Her disease was stage 4 (T2N2M1) ...
OBJECIlVE: To reportthree cases of paclitaxel-induced acutebilateral pneumonitis, as wellas to ascer...
Background: Pulmonary toxicity is a well-known complication observed with several anticancer drugs. ...
Development of pulmonary infiltrates with respiratory symptoms in patients with advanced cancer pres...
Interstitial lung disease associated with docetaxel in a patient treated for breast cancer — a case ...
Docetaxel is a semisynthetic cytostatic drug that belongs to the family of taxoids. Docetaxel inhibi...
Incidence of diffuse alveolar damage is rarely seen after administration of docetaxel used alone or ...
Abstract Taxane‐induced pneumotoxicity is rare. However, 1–5% of patients taking docetaxel may devel...
  Docetaxel belongs to taxane family of antineoplastic agents that are indicated for the treatment...
Pneumonitis is a rare but serious complication of docetaxel treatment. We report a 63-year-old woman...
Paclitaxel is frequently used for the treatment of patients with nonsmall cell lung cancer. Hypersen...
Gemcitabine and docetaxel combination chemotherapy is the standard of care for patients with unresec...
AbstractTaxanes are drugs used to treat many types of cancer, including breast and lung cancer. The ...
Docetaxel has proven effective in many solid tumors, including breast cancer. Hypersensitivity react...
Interstitial lung disease (ILD) is a collective term for a group of disorders that result in inflamm...
A 64-year-old woman was diagnosed with non-small cell lung cancer. Her disease was stage 4 (T2N2M1) ...
OBJECIlVE: To reportthree cases of paclitaxel-induced acutebilateral pneumonitis, as wellas to ascer...